The POU transcription factor Oct-1 represses virus-induced interferon A gene expression

Molecular and Cellular Biology

Volumn 25, Issue 19, 2005, Pages 8717-8731

  Mesplède, Thibault ^a   Island, Marie Laure ^a   Christeff, Nicolas ^a   Petek, Fahrettin ^b   Doly, Janine ^b   Navarro, Sébastien ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; HOMEODOMAIN PROTEIN; INTERFERON REGULATORY FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 1;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMORAL IMMUNITY; IFN A11 GENE; IMMUNE RESPONSE; IMMUNE SYSTEM; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VIRUS INDUCTION; VIRUS INFECTION; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; CELL NUCLEUS; CHROMATOGRAPHY; DNA; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; IMMUNOPRECIPITATION; INTERFERON-ALPHA; MICE; MOLECULAR SEQUENCE DATA; PAIRED BOX TRANSCRIPTION FACTORS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 25444489830     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.19.8717-8731.2005     Document Type: Article

References (60)

1. Advani, S. J., L. O. Durand, R. R. Weichselbaum, and B. Roizman. 2003. Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1. J. Virol. 77:11927-11932.
2. Braganca, J., P. Genin, M. T. Bandu, N. Darracq, M. Vignal, C. Casse, J. Doly, and A. Civas. 1997. Synergism between multiple virus-induced factor-binding elements involved in the differential expression of Interferon A genes. J. Biol. Chem. 272:22154-22162.
3. Brockman, J. L., and L. A. Schuler. 2005. Prolactin signals via StatS and Oct-1 to the proximal cyclin D1 promoter. Mol. Cell. Endocrinol. 239:45-53.
4. Cox, M., N. Dekker, R. Boelens, C. P. Verrijzer, P. C. van der Vliet, R. Kaptein, P. J. Rosenfeld, and T. J. Kelly. 1993. NMR studies of the POU-specific DNA-binding domain of Oct-1: sequential 1H and 15N assignments and secondary structure. Biochemistry 32:6032-6040.
5. Cron, R. Q., B. Zhou, M. W. Brunvand, and D. B. Lewis. 2001. Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells. Genes Immun. 2:464-468.
6. Das, G., and W. Herr. 1993. Enhanced activation of the human histone H2B promoter by an Oct-1 variant generated by alternative splicing. J. Biol. Chem. 268:25026-25032.
7. de Jong, R. N., M. E. Mysiak, L. A. Meijer, M. van der Linden, and P. C. van der Vliet. 2002. Recruitment of the priming protein pTP and DNA binding occur by overlapping Oct-1 POU homeodomain surfaces. EMBO J. 21:725-735.
8. Dekker, N., M. Cox, R. Boelens, C. P. Verrijzer, P. C. van der Vliet, R. Kaptein, P. J. Rosenfeld, and T. J. Kelly. 1993. Solution structure of the POU-specific DNA-binding domain of Oct-1. Nature 362:852-855.
9. Du, W., and T. Maniatis. 1992. An ATF/CREB binding site is required for virus induction of the human Interferon beta gene. Proc. Natl. Acad. Sci. USA 89:2150-2154. (Erratum, 89:5700.)
10. Fletcher, C., N. Heintz, and R. G. Roeder. 1987. Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene. Cell 51:773-781.
11. Ford, E., M. Strubin, and N. Hernandez. 1998. The Oct-1 POU domain activates snRNA gene transcription by contacting a region in the SNAPc largest subunit that bears sequence similarities to the Oct-1 coactivator OBF-1. Genes Dev. 12:3528-3540.
12. Franke, S., G. Scholz, and C. Scheidereit. 1994. Identification of novel ubiquitous and cell type-specific factors that specifically recognize immunoglobulin heavy chain and kappa light chain promoters. J. Biol. Chem. 269:20075-20082.
13. Grenfell, S. J., D. S. Latchman, and N. S. Thomas. 1996. Oct-1 and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases. Biochem. J. 315:889-893. (Erratum, 317:959.)
14. Haggarty, A., R. Camato, G. Paterno, L. Cohen, J. Hiscott, and D. Skup. 1991. A developmentally regulated detainer-binding activity in embryonal carcinoma cells which represses beta-interferon expression. Cell Growth Differ. 2:503-510.
15. Herr, W., R. A. Sturm, R. G. Clerc, L. M. Corcoran, D. Baltimore, P. A. Sharp, H. A. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun, et al. 1988. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2:1513-1516.
16. Hirose, T., Y. Sowa, S. Takahashi, S. Saito, C. Yasuda, N. Shindo, K. Furuichi, and T. Sakai. 2003. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene 22:7762-7773.
17. Iademarco, M. F., J. J. McQuillan, and D. C. Dean. 1993. Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc. Natl. Acad. Sci. USA 90:3943-3947.
18. Iademarco, M. F., J. J. McQuillan, G. D. Rosen, and D. C. Dean. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267:16323-16329.
19. Inamoto, S., N. Segil, Z. Q. Pan, M. Kimura, and R. G. Roeder. 1997. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors. J. Biol. Chem. 272:29852-29858.
20. Island, M.-L., T. Mesplede, N. Darracq, M.-T. Bandu, N. Christeff, P. Djian, J. Drouin, and S. Navarro. 2002. Repression by homeoprotein Pitx1 of virus-induced interferon A promoters is mediated by physical interaction and trans repression of IRF3 and IRF7. Mol. Cell. Biol. 22:7120-7133.
21. Jaffe, J., M. Hochberg, J. Riss, T. Hasin, L. Reich, and R. Laskov. 1995. Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor. Biochim. Biophys. Acta 1261:201-209.
22. Jin, S., F. Fan, W. Fan, H. Zhao, T. Tong, P. Blanck, I. Alomo, B. Rajasekaran, and Q. Zhan. 2001. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Oncogene 20:2683-2690.
23. Karpova, A. Y., M. Trost, J. M. Murray, L. C. Cantley, and P. M. Howley. 2002. Interferon regulatory factor-3 is an in vivo target of DNA-PK. Proc. Natl. Acad. Sci. USA 99:2818-2823.
24. Lee, L., E. Stellar, J. Chang, J. G. Grossmann, R. O'Brien, J. Ladbury, B. Carpenter, S. Roberts, and B. Luisi. 2001. Expression of the Oct-1 transcription factor and characterization of its interactions with the Bob1 coactivator. Biochemistry 40:6580-6588.
25. Lopez, S., M.-L. Island, J. Drouin, M.-T. Bandu, N. Christeff, N. Darracq, R. Barbey, J. Doly, D. Thomas, and S. Navarro. 2000. Repression of virus-induced interferon A promoters by homeodomain transcription factor Ptx1. Mol. Cell. Biol. 20:7527-7540.
26. Lopez, S., R. Reeves, M. L. Island, M. T. Bandu, N. Christeff, J. Doly, and S. Navarro. 1997. Silencer activity in the interferon-A gene promoters. J. Biol. Chem. 272:22788-22799.
27. Magne, S., S. Caron, M. Charon, M. C. Rouyez, and I. Dusanter-Fourt. 2003. STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. Mol. Cell. Biol. 23:8934-8945.
28. Malmgaard, L. 2004. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24:439-454.
29. Mesplede, T., S. Navarro, P. Genin, P. Morin, M. L. Island, E. Bonnefoy, and A. Civas. 2003. Positive and negative control of virus-induced interferon-A gene expression. Autoimmunity 36:447-455.
30. Mitchell, M. S. 2003. Combinations of anticancer drugs and immunotherapy. Cancer Immunol. Immunother. 52:686-692.
31. Mysiak, M. E., C. Wyman, P. E. Holthuizen, and P. C. van der Vliet. 2004. NFI and Oct-1 bend the Ad5 origin in the same direction leading to optimal DNA replication. Nucleic Acids Res. 32:6218-6225.
32. Nogueira, M. L., V. E. Wang, D. Tantin, P. A. Sharp, and T. M. Kristie. 2004. Herpes simplex virus infections are arrested in Oct-1-deficient cells. Proc. Natl. Acad. Sci. USA 101:1473-1478.
33. Osborne, A., H. Zhang, W.-M. Yang, E. Seto, and G. Blanck. 2001. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. Mol. Cell. Biol. 21:6495-6506.
34. Osborne, A. R., H. Zhang, G. Fejer, K. M. Palubin, M. I. Niesen, and G. Blanck. 2004. Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter. J. Biol. Chem. 279:28911-28919.
35. Ossipow, V., U. K. Laemmli, and U. Schibler. 1993. A simple method to renature DNA-binding proteins separated by SDS-polyacrylamide gel electrophoresis. Nucleic Acids Res. 21:6040-6041.
36. Prabhu, A., D. P. O'Brien, G. L. Weisner, R Fulton, and B. Van Ness. 1996. Octamer independent activation of transcription from the kappa immunoglobulin germline promoter. Nucleic Acids Res. 24:4805-4811.
37. Pruijn, G. J., W. van Driel, R. T. van Miltenburg, and P. C. van der Vliet. 1987. Promoter and enhancer elements containing a conserved sequence motif are recognized by nuclear factor III, a protein stimulating adenovirus DNA replication. EMBO J. 6:3771-3778.
38. Roberts, S. B., N. Segil, and N. Heintz. 1991. Differential phosphorylation of the transcription factor Oct1 during the cell cycle. Science 253:1022-1026.
39. Rosenfeld, P. J., and T. J. Kelly. 1986. Purification of nuclear factor I by DNA recognition site affinity chromatography. J. Biol. Chem. 261:1398-1408.
40. Rosenfeld, P. J., E. A. O'Neill, R. J. Wides, and T. J. Kelly. 1987. Sequence-specific interactions between cellular DNA-binding proteins and the adenovirus origin of DNA replication. Mol. Cell. Biol. 7:875-886.
41. Schild-Poulter, C., A. Sbih, N. C. Yarymowich, and R. J. Hache. 2003. Down-regulation of histone H2B by DNA-dependent protein kinase in response to DNA damage through modulation of octamer transcription factor 1. Cancer Res. 63:7197-7205.
42. Schwachtgen, J. L., J. E. Remacle, N. Janel, R. Brys, D. Huylebroeck, D. Meyer, and D. Kerbiriou-Nabias. 1998. Oct-1 is involved in the transcriptional repression of the von Willebrand factor gene promoter. Blood 92:1247-1258.
43. Segil, N., S. B. Roberts, and N. Heintz. 1991. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science 254:1814-1816.
44. 0) cells. Nucleic Acids Res. 32:4390-4399.
45. Strom, A. C., M. Forsberg, P. Lillhager, and G. Westin. 1996. The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression. Nucleic Acids Res. 24:1981-1986.
46. Sturm, R. A., G. Das, and W. Herr. 1988. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev. 2:1582-1599.
47. Suzuki, N., W. Peter, T. Ciesiolka, P. Grass, and H. R. Scholer. 1993. Mouse Oct-1 contains a composite homeodomain of human Oct-1 and Oct-2. Nucleic Acids Res. 21:245-252.
48. Szeto, D. P., A. K. Ryan, S. M. O'Connell, and M. G. Rosenfeld. 1996. P-OTX: a PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc. Natl. Acad. Sci. USA 93:7706-7710.
49. Tagliaferri, P., M. Caraglia, A. Budillon, M. Marra, G. Vitale, C. Viscomi, S. Masciari, P. Tassone, A. Abbruzzese, and S. Venuta. 2005. New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer. Cancer Immunol. Immunother. 54:1-10.
50. Tanaka, M., U. Grossniklaus, W. Herr, and N. Hernandez. 1988. Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements. Genes Dev. 2:1764-1778.
51. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23:307-336.
52. Tremblay, J. J., C. Lanctot, and J. Drouin. 1998. The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Mol. Endocrinol. 12:428-441.
53. Wang, J., M. Satoh, A. Pierani, J. Schmitt, C. H. Chou, H. G. Stunnenberg, R. G. Reeder, and W. H. Reeves. 1994. Assembly and DNA binding of recombinant Ku (p70/p80) autoantigen defined by a novel monoclonal antibody specific for p70/p80 heterodimers. J. Cell Sci. 107:3223-3233.
54. Wang, R. H., H. Yu, and C. X. Deng. 2004. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint. Proc. Natl. Acad. Sci. USA 101:17108-17113.
55. Wang, V. E. H., T. Schmidt, J. Chen, P. A. Sharp, and D. Tantin. 2004. Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice. Mol. Cell. Biol. 24:1022-1032.
56. Wang, V. E., D. Tantin, J. Chen, and P. A. Sharp. 2004. B cell development and immunoglobulin transcription in Oct-1-deficient mice. Proc. Natl. Acad. Sci. USA 101:2005-2010.
57. Wu, G. D., E. J. Lai, N. Huang, and X. Wen. 1997. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J. Biol. Chem. 272:2396-2403.
58. Zhang, H., A. T. Shepherd, D. D. Eason, S. Wei, J. I. Diaz, J. Y. Djeu, G. D. Wu, and G. Blanck. 1999. Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression. Cell Growth Differ. 10:457-465.
59. Zhao, F. Q., Y. Zheng, B. Dong, and T. Oka. 2004. Cloning, genomic organization, expression, and effect on beta-casein promoter activity of a novel isoform of the mouse Oct-1 transcription factor. Gene 326:175-187.
60. Zhao, H., S. Jin, F. Fan, W. Fan, T. Tong, and Q. Zhan. 2000. Activation of the transcription factor Oct-1 in response to DNA damage. Cancer Res. 60:6276-6280.